146 related articles for article (PubMed ID: 6313595)
1. Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation.
Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Mazeron MC; Perol Y
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():161-7. PubMed ID: 6313595
[TBL] [Abstract][Full Text] [Related]
2. [Use of acyclovir in the prevention of herpes infections after allogenic bone marrow grafts].
Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Mazeron MC; Pérol Y
Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):391-6. PubMed ID: 6091231
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir.
Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Nebout T; Mazeron MC; Perol Y
Lancet; 1983 Sep; 2(8352):706-8. PubMed ID: 6136841
[TBL] [Abstract][Full Text] [Related]
4. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
5. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.
Prentice HG
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():153-9. PubMed ID: 6313594
[TBL] [Abstract][Full Text] [Related]
6. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation.
Selby PJ; Powles RL; Easton D; Perren TJ; Stolle K; Jameson B; Fiddian AP; Tryhorn Y; Stern H
Br J Cancer; 1989 Mar; 59(3):434-8. PubMed ID: 2539180
[TBL] [Abstract][Full Text] [Related]
7. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.
Meyers JD; Reed EC; Shepp DH; Thornquist M; Dandliker PS; Vicary CA; Flournoy N; Kirk LE; Kersey JH; Thomas ED
N Engl J Med; 1988 Jan; 318(2):70-5. PubMed ID: 2827025
[TBL] [Abstract][Full Text] [Related]
8. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group.
Prentice HG; Gluckman E; Powles RL; Ljungman P; Milpied N; Fernandez Rañada JM; Mandelli F; Kho P; Kennedy L; Bell AR
Lancet; 1994 Mar; 343(8900):749-53. PubMed ID: 7907729
[TBL] [Abstract][Full Text] [Related]
9. Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients.
Shepp DH; Dandliker PS; Flournoy N; Meyers JD
Transplantation; 1987 May; 43(5):654-8. PubMed ID: 3554658
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir prophylaxis of herpes-simplex-virus infections.
Saral R; Burns WH; Laskin OL; Santos GW; Lietman PS
N Engl J Med; 1981 Jul; 305(2):63-7. PubMed ID: 6264292
[TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.
Balfour HH; Chace BA; Stapleton JT; Simmons RL; Fryd DS
N Engl J Med; 1989 May; 320(21):1381-7. PubMed ID: 2541335
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir prophylaxis in bone marrow transplant recipients.
Lundgren G; Wilczek H; Lönnqvist B; Lindholm A; Wahren B; Ringdén O
Scand J Infect Dis Suppl; 1985; 47():137-44. PubMed ID: 3006228
[TBL] [Abstract][Full Text] [Related]
13. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
Wade JC; Newton B; Flournoy N; Meyers JD
Ann Intern Med; 1984 Jun; 100(6):823-8. PubMed ID: 6326632
[TBL] [Abstract][Full Text] [Related]
14. Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation.
Shepp DH; Dandliker PS; Flournoy N; Meyers JD
J Antimicrob Chemother; 1985 Sep; 16(3):389-95. PubMed ID: 2997101
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.
Hann IM; Prentice HG; Blacklock HA; Ross MG; Brigden D; Rosling AE; Burke C; Crawford DH; Brumfitt W; Hoffbrand AV
Br Med J (Clin Res Ed); 1983 Aug; 287(6389):384-8. PubMed ID: 6307464
[TBL] [Abstract][Full Text] [Related]
17. Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation.
Epstein JB; Ransier A; Sherlock CH; Spinelli JJ; Reece D
Eur J Cancer B Oral Oncol; 1996 May; 32B(3):158-62. PubMed ID: 8762872
[TBL] [Abstract][Full Text] [Related]
18. Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir.
Seale L; Jones CJ; Kathpalia S; Jackson GG; Mozes M; Maddux MS; Packham D
JAMA; 1985 Dec; 254(24):3435-8. PubMed ID: 2999455
[TBL] [Abstract][Full Text] [Related]
19. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.
Shepp DH; Newton BA; Dandliker PS; Flournoy N; Meyers JD
Ann Intern Med; 1985 Jun; 102(6):783-5. PubMed ID: 2986508
[TBL] [Abstract][Full Text] [Related]
20. [Oral prophylaxis of herpes infections using acyclovir following bone marrow transplantation: a clinical and clinico-pharmacological study].
Ehninger G; Vallbracht A; Schüch K; Kumbier I; Dopfer R; Schmidt H; Ostendorf P
Klin Wochenschr; 1986 Jun; 64(12):570-4. PubMed ID: 2426515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
